IP Library › Granted Patent US 8,324,379
Granted Patent B2
US 8,324,379 · App. 13/108,956 · Granted Dec 4, 2012

Prodrugs of heteroaryl compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,324,379
App. No.
13/108,956
Granted
Dec 4, 2012
Kind
B2
Abstract

The present invention provides hydrophobic prodrugs of bases, nucleosides, and nucleotides as well as methods of using the prodrugs as antiviral and anti-cancer chemotherapeutic agents.

Claims (24)

1. A compound having a structure according to Formula I:

wherein

a is 1;

R 2 is (═O), such that b is 0;

R 4 is NR 7 R 8 ;

R 6 is H;

R 7 , R 8 , and R 5 are members independently selected from H, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl and a structure according to formula IV or formula V:

wherein each of R 14 and R 15 is independently selected from substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted acyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl, an amino acid, and a peptide comprising between 2 and 5 amino acids, and

wherein if R 8 is a structure according to Formula IV or Formula V, then R 7 is H; and

R 1 is a structure according to Formula II:

wherein

R 9 is H; and

R 10 and R 11 are —OH

wherein at least one member selected from R 5 , R 7 , and R 8 , together with the nitrogen atom to which it is covalently bonded, is selected from a carbamate and a urea.

2. The compound according to claim 1 , wherein R 5 , R 7 , and R 8 are independently selected from H and a structure according to Formula IV or Formula V.

3. The compound according to claim 2 , wherein each of R 14 and R 15 are independently substituted or unsubstituted alkyl.

4. The compound according to claim 3 , wherein each of R 14 and R 15 are independently unsubstituted alkyl.

5. The compound according to claim 3 , wherein each of R 14 and R 15 are independently unsubstituted C 5 -C 16 alkyl.

6. The compound according to claim 5 , wherein each of R 14 and R 15 are independently selected from n-pentyl, n-hexyl, n-heptyl, n-octyl, 2-ethyl-hexyl, n-nonyl, n-decyl, n-dodecyl and n-hexadecyl.

7. The compound according to claim 5 , wherein R 14 or R 15 is n-heptyl.

8. The compound according to claim 2 , wherein

R 8 is a structure according to Formula IV or Formula V; and

R 5 is H.

9. The compound according to claim 8 , wherein each of R 14 and R 15 are independently selected from n-pentyl, n-hexyl, n-heptyl, n-octyl, 2-ethyl-hexyl, n-nonyl, n-decyl, n-dodecyl and n-hexadecyl.